Loskog AS - Search Results

1

T regulatory cells in B-cell malignancy - tumour support or kiss of death?

Lindqvist CA, Loskog AS. Lindqvist CA, et al. Among authors: loskog as. Immunology. 2012 Apr;135(4):255-60. doi: 10.1111/j.1365-2567.2011.03539.x. Immunology. 2012. PMID: 22112044 Free PMC article. Review.

2

Dendritic cells engineered to express CD40L continuously produce IL12 and resist negative signals from Tr1/Th3 dominated tumors.

Loskog A, Ninalga C, Tötterman TH. Loskog A, et al. Cancer Immunol Immunother. 2006 May;55(5):588-97. doi: 10.1007/s00262-005-0051-4. Epub 2005 Sep 21. Cancer Immunol Immunother. 2006. PMID: 16175400 Free PMC article.

3

The T-cell pool is anergized in patients with multiple sclerosis in remission.

Fransson ME, Liljenfeldt LS, Fagius J, Tötterman TH, Loskog AS. Fransson ME, et al. Among authors: loskog as. Immunology. 2009 Jan;126(1):92-101. doi: 10.1111/j.1365-2567.2008.02881.x. Epub 2008 Jun 24. Immunology. 2009. PMID: 18624727 Free PMC article.

4

Midgut carcinoid patients display increased numbers of regulatory T cells in peripheral blood with infiltration into tumor tissue.

Vikman S, Sommaggio R, De La Torre M, Oberg K, Essand M, Giandomenico V, Loskog A, Totterman TH. Vikman S, et al. Acta Oncol. 2009;48(3):391-400. doi: 10.1080/02841860802438495. Acta Oncol. 2009. PMID: 18855160

5

Adenovirus delivery of human CD40 ligand gene confers direct therapeutic effects on carcinomas.

Vardouli L, Lindqvist C, Vlahou K, Loskog AS, Eliopoulos AG. Vardouli L, et al. Among authors: loskog as. Cancer Gene Ther. 2009 Nov;16(11):848-60. doi: 10.1038/cgt.2009.31. Epub 2009 May 22. Cancer Gene Ther. 2009. PMID: 19461675

6

The Janus faces of CD40 in cancer.

Loskog AS, Eliopoulos AG. Loskog AS, et al. Semin Immunol. 2009 Oct;21(5):301-7. doi: 10.1016/j.smim.2009.07.001. Epub 2009 Jul 31. Semin Immunol. 2009. PMID: 19647448 Review.

7

Local AdCD40L gene therapy is effective for disseminated murine experimental cancer by breaking T-cell tolerance and inducing tumor cell growth inhibition.

Lindqvist C, Sandin LC, Fransson M, Loskog A. Lindqvist C, et al. J Immunother. 2009 Oct;32(8):785-92. doi: 10.1097/CJI.0b013e3181acea69. J Immunother. 2009. PMID: 19752755

8

T regulatory cells lacking CD25 are increased in MS during relapse.

Fransson M, Burman J, Lindqvist C, Atterby C, Fagius J, Loskog A. Fransson M, et al. Autoimmunity. 2010 Dec;43(8):590-7. doi: 10.3109/08916930903541190. Epub 2010 Apr 7. Autoimmunity. 2010. PMID: 20370571 Free article.

9

AdCD40L immunogene therapy for bladder carcinoma--the first phase I/IIa trial.

Malmström PU, Loskog AS, Lindqvist CA, Mangsbo SM, Fransson M, Wanders A, Gårdmark T, Tötterman TH. Malmström PU, et al. Among authors: loskog as. Clin Cancer Res. 2010 Jun 15;16(12):3279-87. doi: 10.1158/1078-0432.CCR-10-0385. Epub 2010 May 4. Clin Cancer Res. 2010. PMID: 20448220 Clinical Trial.

10

T regulatory cells control T-cell proliferation partly by the release of soluble CD25 in patients with B-cell malignancies.

Lindqvist CA, Christiansson LH, Simonsson B, Enblad G, Olsson-Strömberg U, Loskog AS. Lindqvist CA, et al. Among authors: loskog as. Immunology. 2010 Nov;131(3):371-6. doi: 10.1111/j.1365-2567.2010.03308.x. Immunology. 2010. PMID: 20518821 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters